about
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.From Diabetes Care to Diabetes Cure-The Integration of Systems Biology, eHealth, and Behavioral Change.Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion.Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PPARs and nonalcoholic fatty liver disease.
@en
PPARs and nonalcoholic fatty liver disease.
@nl
type
label
PPARs and nonalcoholic fatty liver disease.
@en
PPARs and nonalcoholic fatty liver disease.
@nl
prefLabel
PPARs and nonalcoholic fatty liver disease.
@en
PPARs and nonalcoholic fatty liver disease.
@nl
P2860
P1433
P1476
PPARs and nonalcoholic fatty liver disease.
@en
P2093
Brian N Finck
Kim H H Liss
P2860
P356
10.1016/J.BIOCHI.2016.11.009
P577
2016-12-02T00:00:00Z